Two important changes have been made to Medicare Part D in 2025 that may help make the cost of your prescription drugs more affordable and more manageable.
Continue Reading
NIH hosts visit for people with myositis
By Lindsay Key People living with myositis learned about research to advance understanding and treatment of the disease during presentations and a tour of the National Institutes of Health (NIH)…
Continue Reading
TMA’s Women of Color raise the bar for advocacy and support
Kaniah Gunter and Holly Jones
Continue Reading
Karen Alexander: TMA’s 2024 Patient Ambassador Awardee
The Myositis Association (TMA) is thrilled to recognize Karen Alexander, a groundbreaking Black supermodel who was diagnosed with dermatomyositis in 2016. Karen will be honored with TMA’s Heroes in the…
Continue Reading
Dermatomyositis: A many-headed monster
The first-ever Externally Led Patient Focused Drug Development (EL-PFDD) meeting on June 7 offered a critical way for patients and their family members to highlight what life with DM is like.
Continue Reading